Search

Your search keyword '"Halder, Saiti"' showing total 13 results
Start Over Author "Halder, Saiti" Publication Year Range Last 50 years
13 results on '"Halder, Saiti"'

4. MYOCARDIAL IMPACT OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) SECRETOMES IN CARDIO-ONCOLOGY PATIENTS

Author

Kwan, Jennifer, primary, Vanoudenhove, Jennifer, additional, Halder, Saiti, additional, Biancon, Giulia, additional, Jain, Kanika, additional, Chakraborty, Raja, additional, Lustberg, Maryam, additional, Pusztai, Lajos, additional, Campbell, Stuart, additional, Zhao, Hongyu, additional, Halene, Stephanie, additional, and Hwa, John, additional

Published
2022
Full Text
View/download PDF

7. Biocompatibility of nanomaterials and their immunological properties

Author

Kyriakides, Themis R, primary, Raj, Arindam, additional, Tseng, Tiffany H, additional, Xiao, Hugh, additional, Nguyen, Ryan, additional, Mohammed, Farrah S, additional, Halder, Saiti, additional, Xu, Mengqing, additional, Wu, Michelle J, additional, Bao, Shuozhen, additional, and Sheu, Wendy C, additional

Published
2021
Full Text
View/download PDF

13. Distinct mechanisms drive divergent phenotypes in hypertrophic and dilated cardiomyopathy associated TPM1 variants.

Author

Halder SS, Rynkiewicz MJ, Kim L, Barry M, Zied AG, Sewanan LR, Kirk JA, Moore JR, Lehman W, and Campbell SG

Abstract

Hypertrophic and dilated cardiomyopathies (HCM and DCM, respectively) are inherited disorders that may be caused by mutations to the same sarcomeric protein but have completely different clinical phenotypes. The precise mechanisms by which point mutations within the same gene bring about phenotypic diversity remain unclear. Our objective has been to develop a mechanistic explanation of diverging phenotypes in two TPM1 mutations, E62Q (HCM) and E54K (DCM). Drawing on data from the literature and experiments with stem cell-derived cardiomyocytes expressing the TPM1 mutations of interest, we constructed computational simulations that provide plausible explanations of the distinct muscle contractility caused by each variant. In E62Q, increased calcium sensitivity and hypercontractility was explained most accurately by a reduction in effective molecular stiffness of tropomyosin and alterations in its interactions with the actin thin filament that favor the 'closed' regulatory state. By contrast, the E54K mutation appeared to act via long-range allosteric interactions to increase the association rate of the C-terminal troponin I mobile domain to tropomyosin/actin. These mutation-linked molecular events produced diverging alterations in gene expression that can be observed in human engineered heart tissues. Modulators of myosin activity confirmed our proposed mechanisms by rescuing normal contractile behavior in accordance with predictions.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results